|
Volumn 112, Issue 1, 2013, Pages 26-31
|
Impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC) on prostate-specific antigen (PSA) testing by Dutch general practitioners
|
Author keywords
European Randomized Study of Screening for Prostate Cancer (ERSPC); follow up; general practice; guidelines; prostate cancer; prostate specific antigen (PSA)
|
Indexed keywords
PROSTATE SPECIFIC ANTIGEN;
ADULT;
AGED;
ARTICLE;
CANCER SCREENING;
CONTROLLED STUDY;
FOLLOW UP;
GENERAL PRACTITIONER;
HEALTH INSURANCE;
HUMAN;
MALE;
NETHERLANDS;
PATIENT REFERRAL;
PHYSICIAN ATTITUDE;
PRIORITY JOURNAL;
PROSTATE CANCER;
RETROSPECTIVE STUDY;
SCREENING TEST;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTIGENS, NEOPLASM;
EARLY DETECTION OF CANCER;
FOLLOW-UP STUDIES;
HUMANS;
INCIDENCE;
MALE;
MASS SCREENING;
MIDDLE AGED;
NETHERLANDS;
PROGNOSIS;
PROSTATE;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
RETROSPECTIVE STUDIES;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 84879125355
PISSN: 14644096
EISSN: 1464410X
Source Type: Journal
DOI: 10.1111/bju.12029 Document Type: Article |
Times cited : (15)
|
References (8)
|